TDC
BHC icon

Thompson Davis & Co’s Bausch Health BHC Stock Holding History

Thompson Davis & Co’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,025
Closed -$387K – 111
2021
Q4 		$387K Buy
+14,025
New +$375K 0.32% 57
2018
Q1 		– Sell
-500
Closed -$10K – 631
2017
Q4 		$10K Buy
500
+250
+100% +$3.96K 0.02% 409
2017
Q3 		$4K Hold
250
– – 0.01% 880
2017
Q2 		$4K Buy
250
+224
+862% +$2.69K 0.01% 871
2017
Q1 		$0 Sell
26
-250
-91% -$3.44K ﹤0.01% 1150
2016
Q4 		$4K Sell
276
-125
-31% -$2.29K 0.01% 895
2016
Q3 		$10K Buy
401
+375
+1,442% +$9.71K 0.02% 659
2016
Q2 		$1K Sell
26
-64
-71% -$1.81K ﹤0.01% 1004
2016
Q1 		$2K Buy
90
+22
+32% +$1.63K ﹤0.01% 940
2015
Q4 		$7K Buy
68
+39
+134% +$4.38K 0.01% 753
2015
Q3 		$5K Sell
29
-748
-96% -$174K 0.01% 830
2015
Q2 		$173K Sell
777
-1
-0.1% -$222 0.2% 109
2015
Q1 		$155K Sell
778
-6
-0.8% -$1.06K 0.19% 119
2014
Q4 		$112K Sell
784
-52
-6% -$6.99K 0.13% 163
2014
Q3 		$110K Buy
+836
New +$99.7K 0.14% 152
2014
Q1 		– Sell
-4,103
Closed -$482K – 806
2013
Q4 		$482K Buy
+4,103
New +$450K 0.73% 34

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return

Thompson Davis & Co's BHC Position: Q1 2022 in Review

Thompson Davis & Co sold out of Bausch Health (BHC) in Q1 2022, closing a stake of 14,025 shares — an estimated $387K sold.

Thompson Davis & Co first reported a position in BHC in Q4 2013 and held it in 16 quarters. The position peaked at $482K in Q4 2013. 370 funds tracked by Wall St. Rank hold BHC as of Q1 2022.

  • Thompson Davis & Co reported no remaining Bausch Health position as of Q1 2022 after selling out during the quarter.
  • Thompson Davis & Co sold 14,025 Bausch Health shares in Q1 2022, an estimated $387K.
  • Thompson Davis & Co first reported a position in Bausch Health in Q4 2013 and held it in 16 quarters.
  • Thompson Davis & Co's Bausch Health position peaked at $482K in Q4 2013.
  • 370 funds tracked by Wall St. Rank held Bausch Health as of Q1 2022.

Based on Thompson Davis & Co's 13F filing for Q1 2022, filed 13 May 2022.